Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Genochondromatosis is characterized by chondromatosis, typically involving the clavicles, upper end of the humerus, and lower end of the femur. Lesions are bilateral and symmetrical. It has been described four patients from the same family and is transmitted as an autosomal dominant trait. Another disorder, genochondromatosis II, shows strong similarities to genochondromatosis but is characterized by the involvement of the short tubular bones and by normal clavicles. It has been described in one unrelated family. Genochondromatosis II may also be inherited as an autosomal dominant trait. Genochondromatosis has a benign clinical course.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for genochondromatosis type 1.
3 publications have been identified in PubMed for genochondromatosis type 1. Research spans Case Report / Case Series (67%) and Epidemiology / Natural History (33%).
Son WS (2025). [PMID: 41084766](https://pubmed.ncbi.nlm.nih.gov/41084766/). *J Yeungnam Med Sci*. [Case Report / Case Series]
Kabra A (2025). [PMID: 40688934](https://pubmed.ncbi.nlm.nih.gov/40688934/). *Cureus*. [Case Report / Case Series]
Salduz A (2024). [PMID: 39058880](https://pubmed.ncbi.nlm.nih.gov/39058880/). *Medicine (Baltimore)*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 9:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center